Alzheimer's drug lecanemab hailed as momentous breakthrough

TL;DR

Amyloid is a protein that clumps together in the spaces between neurons in the brain and forms distinctive plaques that are one of the hallmarks of Alzheimer's.David said: "If somebody can slow it [Alzheimer's] down and eventually stop it all together that would be brilliant, it's just a horrible nasty thing."Prof Spires-Jones said that was a "small effect" on the disease, but "even though it is not dramatic, I would take it".Dr Elizabeth Coulthard, who treats patients at North Bristol NHS Trust, says that people have, on average, six years of living independently once mild cognitive impairment starts.She said that, currently, only those living near big medical centres or paying privately were likely to benefit."

Like summarized versions? Support us on Patreon!